We are live on ! Find out more
SFCM

Seven Fleet Capital Management Portfolio holdings

AUM $318M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$318M
AUM Growth
+$170M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
144
New
Increased
Reduced
Closed

Top Buys

1
+$6.2M
2
+$5.04M
3
+$4.51M
4
TNGX icon
Tango Therapeutics
TNGX
+$3.99M
5
TYRA icon
Tyra Biosciences
TYRA
+$3.76M

Top Sells

1
+$81.6M
2
+$5.27M
3
+$3.01M
4
COGT icon
Cogent Biosciences
COGT
+$2.39M
5
BLTE
Belite Bio
BLTE
+$1.47M

Sector Composition

1 Healthcare 55.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLYM
51
Climb Bio
CLYM
$749M
$895K 0.28%
130,654
+54,254
CMPS
52
Compass Pathways
CMPS
$2B
$874K 0.27%
158,021
+118,021
ALKS icon
53
Alkermes
ALKS
$9.18B
$855K 0.27%
+24,170
SLN
54
Silence Therapeutics
SLN
$479M
$826K 0.26%
156,759
+9,159
CRBP icon
55
Corbus Pharmaceuticals
CRBP
$162M
$805K 0.25%
85,687
+28,937
CELC icon
56
Celcuity
CELC
$4.87B
$685K 0.22%
6,000
-2,338
ANTX icon
57
AN2 Therapeutics
ANTX
$187M
$683K 0.21%
+199,701
DNLI icon
58
Denali Therapeutics
DNLI
$4.06B
$677K 0.21%
+35,286
UTHR icon
59
United Therapeutics
UTHR
$23B
$669K 0.21%
1,128
-172
LLY icon
60
Eli Lilly
LLY
$1.08T
$662K 0.21%
+720
VSTM icon
61
Verastem
VSTM
$332M
$654K 0.21%
123,400
+108,260
GERN icon
62
Geron
GERN
$847M
$632K 0.2%
424,180
-353,700
IRD
63
Opus Genetics
IRD
$330M
$611K 0.19%
+134,242
IKT icon
64
Inhibikase Therapeutics
IKT
$252M
$547K 0.17%
325,600
-208,048
CNTX icon
65
Context Therapeutics
CNTX
$53.3M
$500K 0.16%
+190,785
DRUG
66
Bright Minds Biosciences
DRUG
$646M
$467K 0.15%
+6,395
VYGR icon
67
Voyager Therapeutics
VYGR
$217M
$445K 0.14%
+115,203
GPCR icon
68
Structure Therapeutics
GPCR
$3.53B
$434K 0.14%
+9,000
PTGX icon
69
Protagonist Therapeutics
PTGX
$7.84B
$422K 0.13%
4,000
-4,000
PRTA icon
70
Prothena Corp
PRTA
$525M
$421K 0.13%
43,300
NTLA icon
71
Intellia Therapeutics
NTLA
$2.33B
$404K 0.13%
+31,500
MIST icon
72
Milestone Pharmaceuticals
MIST
$154M
$397K 0.12%
+333,333
SABS icon
73
SAB Biotherapeutics
SABS
$291M
$383K 0.12%
+100,000
PALI icon
74
Palisade Bio
PALI
$328M
$373K 0.12%
213,100
-114,400
GLUE icon
75
Monte Rosa Therapeutics
GLUE
$1.88B
$371K 0.12%
22,530
+18,530
1 2
3
4 5